Royalty Pharma Stock (NASDAQ: RPRX) stock price, news, charts, stock research, profile.
|Vol / Avg.100.508K / 2.157M||Mkt Cap11.886B|
|Day Range26.611 - 27.010||52 Wk Range25.920 - 44.460|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-09||Morgan Stanley||Terence Flynn||Maintains||OverweightOverweight||Raises||54.00||57.00|
|2023-10-11||Morgan Stanley||Terence Flynn||Maintains||OverweightOverweight||Raises||53.00||54.00|
|2023-08-09||Morgan Stanley||Terence Flynn||Maintains||OverweightOverweight||Raises||52.00||53.00|
|2023-07-11||Morgan Stanley||Terence Flynn||Reiterates||OverweightOverweight||Maintains||52.00||52.00|
|Ticker||Company||Chg %||Mkt Cap|
|JNJ||Johnson & Johnson||0.4%||367.6B|
|MRK||Merck & Co||-0.46%||255.1B|
You can purchase shares of Royalty Pharma (NASDAQ: RPRX) through any online brokerage.
The latest price target for Royalty Pharma (NASDAQ: RPRX) was reported by Morgan Stanley on Thursday, November 9, 2023. The analyst firm set a price target for 57.00 expecting RPRX to rise to within 12 months (a possible 114.21% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Royalty Pharma (NASDAQ: RPRX) is $26.61 last updated Today at November 30, 2023 at 3:01 PM UTC.
A quarterly cash dividend of $0.20 per share of Class A Common Stock. The quarterly cash dividend was payable on December 15, 2023 to stockholders of record on November 16, 2023.
Royalty Pharma’s Q4 earnings are confirmed for Wednesday, February 14, 2024.
There is no upcoming split for Royalty Pharma.
Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.